Results 51 to 60 of about 2,055 (186)

Central retinal artery occlusion and non-arteritic anterior ischemic optic neuropathy associated with an overlap syndrome: a case report

Journal of Medical Case Reports, 2008
Introduction An "overlap syndrome" is defined as the sequential appearance over time of two or more risk factors for glaucomatous damage. The appearance of a new risk factor can alter the course and prognosis of previously stable disease.
Lima Verônica C, Prata Tiago S, Liebmann Jeffrey M, Ritch Robert   +3 more
doaj   +1 more source

Color vision in anterior ischemic optic neuropathy

American Journal of Ophthalmology Case Reports, 2020
Purpose: The non-arteritic form of anterior ischemic optic neuropathy (AION) is the most common acute optic neuropathy among individuals over the age of fifty, yet little is known about how the disorder affects color vision. We tested the hypothesis that
Stephen C. Pollock, Raymond E. Hubbe
doaj   +1 more source

Non-arteritic anterior ischemic optic neuropathy versus cerebral ischemic stroke [PDF]

Graefe's Archive for Clinical and Experimental Ophthalmology, 2012
Non-arteritic anterior ischemic optic neuropathy (NAAION) is a common, visually disabling disease. However, its pathogenesis and management have been highly controversial. There is a common belief that NA-AION and cerebral ischemic stroke are similar in nature pathogenetically and in management.
openaire   +2 more sources

Systemic oxidative stress in non-arteritic anterior ischemic optic neuropathy [PDF]

Eye, 2019
To investigate whether the serum total oxidant status (TOS), total antioxidant status (TAS), advanced oxidation protein products (AOPP), and thiol parameters could play a role in the pathogenesis of non-arteritic anterior ischemic optic neuropathy (NA-AION).In this study, 18 newly diagnosed NA-AION patients and 17 healthy subjects (control group) were ...
Serife, Birer, Hatice, Arda, Deniz, Kilic, Gulden, Baskol   +3 more
openaire   +2 more sources

The Association Between Phosphodiesterase Type 5 Inhibitor Use and Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy: A Systematic Review and Meta-Analysis

Sexual Medicine, 2018
Introduction: Phosphodiesterase type 5 inhibitors (PDE5-Is) are first-line drugs for erectile dysfunction. Non-arteritic anterior ischemic optic neuropathy (NAION) has been linked with PDE5-I use.
Bing Liu, MD, Linxin Zhu, MM, Jingxiang Zhong, MD, Guohua Zeng, MD, Tuo Deng, MD   +4 more
doaj   +1 more source

NON-ARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY SECONDARY TO TADALAFIL USE [PDF]

Spartan Med Res J
Mellema, Paige, Deutmeyer, Blake, Wasielewski, Paul   +2 more
europepmc   +2 more sources

Intravitreal allogeneic mesenchymal stem cells: a non-randomized phase II clinical trial for acute non-arteritic optic neuropathy

Stem Cell Research & Therapy, 2023
Background An effective treatment for acute non-arteritic ischemic optic neuropathy (NA-AION) has not been known or proven yet. Previous studies have suggested a neuroprotective effect of allogeneic bone marrow-derived mesenchymal stem cells.
Jose C. Pastor, Salvador Pastor-Idoate, Marina López-Paniagua, Marta Para, Francisco Blazquez, Esther Murgui, Verónica García, Rosa M. Coco-Martín   +7 more
doaj   +1 more source

Ischemic Optic Neuropathy: A Review of Current and Potential Future Pharmacotherapies

Pharmaceuticals
The treatment of arteritic anterior ischemic optic neuropathy (AAION), non-arteritic ischemic optic neuropathy (NAAION), and posterior ischemic optic neuropathy (PION) is a topic of ongoing research with mixed evidence on some pharmacotherapies and a ...
Omar Badla, Beshr Abdulaziz Badla, Amr Almobayed, Carlos Mendoza, Krishna Kishor, Sanjoy K. Bhattacharya   +5 more
doaj   +1 more source

Frontal Tuberculoma Presenting With Atypical Foster Kennedy Syndrome in a Pregnant Patient

Clinical Case Reports, Volume 13, Issue 10, October 2025.
ABSTRACT Foster Kennedy syndrome (FKS), accounting for 1%–2.5% of intracranial masses, typically arises in the frontal lobe and may result from various etiologies, including rare causes such as tuberculoma. Although the incidence of central nervous system (CNS) tuberculosis is increasing, published reports in this setting remain scarce.
Kevin Aviles‐Largaespada, Arlen Montoya‐Rodriguez, Milton Hernández, Adrian Coulson, Mohammed Zahran   +4 more
wiley   +1 more source

Study Design and Rationale for The Breathe Easier With Tadalafil Therapy for Exercise‐Related Dyspnea in COPD‐PH (BETTER COPD‐PH)

Pulmonary Circulation, Volume 15, Issue 4, October 2025.
ABSTRACT Dyspnea, a debilitating symptom of COPD, worsens health‐related quality of life (HRQL), reduces daily physical activity, increases health care utilization, and is more closely associated with survival than airflow limitation. Thus, having treatments that reduce dyspnea in COPD is important.
Elena DeSanti, Matthew Jankowich, Gaurav Choudhary, Alan Morrison, Zachary K. Stanley, Eric Garshick, Marilyn L. Moy, Mohleen Kang, Cherry Wongtrakool, Ruxana T. Sadikot, Edward C. Dempsey, Matthew Griffith, Duc M. Ha, Christopher H. Schmid, Ronald H. Goldstein, Sharon Rounds, the BETTER COPD‐PH Study Group, Jayashri Aragam, Brack Hattler, Tim Lahm, Kristin L. Bailey, Debra Romberger, Gautam Kumar, Joshua Detelich, Jussi Saukkonen, Emily Wan, Shelsey Johnson, Malisa Barber, Christopher Halladay, Kathleen LaCerda, Renee LeClaire, Alexis Thavenet, Makkawi Makkawi, Mehret Tekle, Susan Burbach, Jenna Eggert, Julia Gillotti, Sridhar Tanukonda, Tiffany Elliott, Radhika Mungara, Matthew Lejy   +40 more
wiley   +1 more source